NQ Global Startup Gateway
Elevating future-medicine startups to a global standard.
From Nakanoshima Qross ー
a global, execution-driven program for startup development and co-creation.

NEWS

Elevating future-medicine startups to a global standard.
From Nakanoshima Qross ー
a global, execution-driven program for startup development and co-creation.

Elevating future-medicine startups to a global standard.
From Nakanoshima Qross ー
a global, execution-driven program for startup development and co-creation.

From Nakanoshima Qross—Osaka’s hub for next-generation healthcare—we advance promising life-science startups to world-class.
NQ Global Startup Gateway is a program that aggregates and accelerates startups to build a world-class, globally competitive ecosystem and create globally active ventures.
Through collaboration with global accelerators, investors, and corporates, we provide hands-on support and international networks to help startups expand globally from Nakanoshima Qross.

PROGRAMS

Global Accelerator Program
NQ Health Accelerator Program

Creating global startups through the provision of tailor-made startup support programs and overseas travel support programs. AstraZeneca, Cambridge Consultants, and MedTech Actuator collaborate on this program focused on overseas market development.

NQ version
COO HR Development Program

The “Nakanoshima Qross COO Development Program” is a talent-development initiative for Japan-based startups, adapted from 82VS Venture Studios (Alloy Therapeutics) and its COO (Chief Operating Officer) training program run for U.S. startups.

NQ version
Bio-Catalyst AI Accelerator Program

This program leverages Deep Intelligent Pharma’s cutting-edge AI and global domain expertise to transform promising startups into investor-ready companies.

Osaka-Kansai Cluster

Life Science Potential of Osaka/Kansai

Osaka and the Kansai region has a long history as a center of the pharmaceutical and medical device industries, and is home to Japan's top-ranked research institutes and R&D centers of many major companies. This concentration has provided a solid foundation for world-class R&D and business creation, especially in the life science field, and for driving the future of health and medical care. It forms a robust ecosystem that supports everything from basic research to clinical application and commercialization, making it an ideal environment for the creation of global innovations.
In particular, the three centers in Osaka, "Nakanoshima," "Kento," and "Saito," each with different functions and strengths, will collaborate with each other to create innovations in the life science field The NQ Global Startup Gateway will leverage the potential of Osaka and the Kansai region to attract innovative startups, investors, and support organizations from Japan and abroad The NQ Global Startup Gateway will promote the attraction and collaboration of innovative startups, investors, and support organizations from Japan and abroad, taking advantage of the potential of Osaka and Kansai.

Join the Osaka/Kansai ecosystem and open the door to global opportunities!

Participate in the Osaka/Kansai ecosystem,
Why not open the door to globalization?

The "NQ Global Startup Gateway" will strongly support global expansion by maximizing the potential of the robust Osaka/Kansai life science cluster.

NQ Global Startup Gateway
(in Japanese history)Nakanoshima Cross Global Startup Creation and Location Promotion Project)


NQ Global Startup Gateway Joint Venture

AstraZeneca Corporation

Cambridge Consultants, Inc.

Medtec Actuator LLC

ALLOY THERAPEUTICS Co.

Deep Intelligent Pharma, Inc.

MIRACLE SCIENCE INNOVATION
Corporation (Representative Company)